New Delhi: After US President Donald Trump’s comment on Hydroxycholoquine was interpreted as the US seeking retaliation if India stops the export of the anti-malaria drug to the United States, Donald Trump said Indian Prime Minister Narendra Modi was “great” when he sought his help to allow the sale of the anti-malaria drug to treat the growing number of COVID-19 patients in the US. Also Read - Canadian PM Justin Trudeau Takes Knee in #BlackLivesMatter Protest, Americans Tell Donald Trump 'This is What Real Leader Does'

India on Tuesday allowed the export of hydroxychloroquine to the US. Also Read - BJP Leader Kapil Mishra Grabs Negative Limelight For India as Mark Zuckerberg Criticises His Delhi Riots Threat in Facebook’s Hate Speech Policy



Trump and Prime Minister Modi spoke over the phone last week. During the call, Trump requested Modi to lift the hold on the American order of hydroxychloroquine, of which India is the major producer. Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York. Anticipating that it will work, given initial positive results, Trump has bought more than 29 million doses of hydroxychloroquine for potential treatment of COVID-19 patients. Also Read - Twitter CEO Jack Dorsey And US President Donald Trump Lock Horns Again, This Time Over Latter's Campaign Video Which Had 'Copyright' Issues

“I bought millions of doses (of hydroxychloroquine). More than 29 million. I spoke to Prime Minister Modi, a lot of it (hydroxychloroquine) comes out of India. I asked him if he would release it? He was Great. He was really good,” Trump told Sean Hannity of the Fox News on Monday night.



“You know they put a stop because they wanted it for India, Trump said responding to a question on the usage of hydroxychloroquine.

Hydroxychloroquine, an old and inexpensive drug used to treat malaria, is seen as a viable therapeutic solution by President Trump to coronavirus.

Apart from the US, India has received similar requests from several other countries including its immediate neighbours Sri Lanka and Nepal. India has said that it is reviewing its export ban order.

India’s decision to ban the exports of hydroxychloroquine is driven by its desire to take stock of the domestic requirements and ensure that the country has enough of the drug.

India manufactures 70 per cent of the world’s supply of hydroxychloroquine, according to Indian Pharmaceutical Alliance (IPA) secretary-general Sudarshan Jain. The country has a production capacity of 40 tonnes of hydroxychloroquine (HCQ) every month, implying 20 crore tablets of 200 mg each. And since the drug is also used to auto-immune diseases like rheumatoid arthritis and lupus, manufacturers have good production capacities that can also be ramped up.

(With PTI Inputs)